A Startup Bets It Can Replace Prior Authorization With Real-Time Clinical Oversight
Otter Health, a Washington, D.C. startup building software that monitors whether doctors follow evidence-based treatment guidelines, announced on Oct 15, 2026, that it raised $8 million in a seed round co-led by Fika Ventures and Evidenced. The round drew participation from Slow Ventures, Metrodora, CoFound Partners, Layout Ventures, Patient Capital and SemperVirens.
The pitch is ambitious: replace the widely despised prior authorization process—in which insurers review and approve treatments before they happen—with a system that tracks physician decisions in real time and nudges them toward standard-of-care pathways. Instead of requiring doctors to seek permission, Otter's platform shows them how often their choices align with clinical guidelines, flags outliers, and sends alerts when a treatment plan veers off course.
In early deployments where organizations dropped prior authorization requirements and adopted Otter's platform, fewer than 5% of clinical decisions fell outside accepted care standards, the company said. Otter declined to name the health plans and provider groups using its software, citing confidentiality agreements.
The founding team brings a mix of academic credibility and startup experience. Co-founder Amol Navathe, a professor at the University of Pennsylvania and Wharton who formerly served as vice chair of the Medicare Payment Advisory Commission, previously co-founded Embedded Healthcare, which Clarify Health acquired in 2022. CEO Keith Florance ran Embedded as president and led Clarify's payer business after the acquisition; before that, he worked at Boston Consulting Group and Evolent Health. CTO Ram Keralapura, who holds more than 20 U.S. patents, led data science and machine learning at Google Cloud Security following an earlier acquisition. Chief Product Officer Will Bartlett studied at Georgia Tech and Wharton and focused his medical training at the Icahn School of Medicine on applying machine learning to utilization management.
The advisory board includes Ezekiel Emanuel and Kate Goodrich, the former chief medical officer at both the Centers for Medicare & Medicaid Services and Humana, who now serves as executive in residence at Optum.
Otter's software analyzes individual treatment decisions and compares them against evidence-based pathways. Physicians see dashboards displaying their concordance rates, peer comparisons, and alerts—delivered by text or app—when their decisions stray from guidelines or lack proper documentation. The system works across different electronic health record platforms and serves health plans, hospital systems, and risk-bearing physician groups.
The company describes this as "provider-led utilization management," a framework that extends oversight beyond the handful of expensive procedures typically governed by prior authorization to a wider range of potentially unnecessary or low-value care.
The funding arrives as federal regulators tighten rules around prior authorization. Recent CMS regulations have imposed stricter decision timelines and added requirements for application programming interfaces to streamline the process, though implementation has faced delays. A government pilot program testing AI tools for prior authorization encountered tech failures and workflow friction, according to industry reports.
Physicians have long complained about the administrative burden. Survey data from the American Medical Association, collected in 2021, found that doctors complete dozens of prior authorizations each week, with most reporting treatment delays and many noting patients abandon care entirely because of the approval process.
Several companies already sell software to automate parts of prior authorization, including Cohere Health, eviCore, Availity and Waystar. Otter positions itself differently—not as a way to make prior authorization faster, but as a replacement that eliminates the approval step and substitutes transparency around clinical decision-making.
"Otter Health is taking a different approach by creating better visibility into care appropriateness itself," said Bryan Sivak, managing partner at Evidenced and former chief technology officer at the U.S. Department of Health and Human Services, in a statement.
Goodrich, speaking as an advisor, described the platform as "a great opportunity to support clinicians" during the broader shift toward value-based payment models. Florance told FierceHealthcare the company represents "the new way that we measure quality."
Otter said it plans to use the capital to scale its platform, expand into additional medical specialties, and hire more engineers and physicians. The company is currently recruiting for roles including a consulting physician focused on evidence-based care pathways, according to its careers page.
Whether health systems and insurers will accept a model that relies on physician self-monitoring rather than upfront approval remains an open question. The early results Otter cited suggest some organizations are willing to test the approach, though the sample size and context remain limited. For now, the startup is betting that real-time visibility and gentle nudges can accomplish what prior authorization attempts through gatekeeping and paperwork.
